Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride shows promise for female hair loss, but more research needed.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Higher androgen levels do not cause baldness in men.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.